3.32
                                            Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
How SciSparc Ltd. stock performs in interest rate cycles2025 EndofYear Setup & Fast Momentum Entry Tips - newser.com
Will SciSparc Ltd. bounce back from current supportWeekly Trade Review & High Conviction Buy Zone Alerts - newser.com
Heatmap analysis for SciSparc Ltd. and competitorsJuly 2025 Review & Accurate Intraday Trade Tips - newser.com
Is SciSparc Ltd. stock entering bullish territory2025 Big Picture & Low Risk Entry Point Tips - newser.com
Live market analysis of SciSparc Ltd.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Tools to monitor SciSparc Ltd. recovery probabilityVolume Spike & Weekly High Momentum Picks - newser.com
Is SciSparc Ltd. stock a top momentum playJuly 2025 Retail & AI Based Buy/Sell Signal Reports - newser.com
SciSparc Ltd. (SPRC) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Scisparc Ltd (SPRC) Stock Price, News & Analyst Forecast - eToro
N2OFF (NASDAQ: NITO) closes MitoCareX merger; issues 40% of fully diluted shares - Stock Titan
Is SciSparc Ltd. stock in correction or buying zoneWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
SciSparc’s SCI-110 Study: A Potential Game-Changer for Tourette Syndrome - TipRanks
SciSparc gets Nasdaq extension to regain compliance - MSN
SciSparc Ltd. stock retracement – recovery analysis2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
What dividend safety score for SciSparc Ltd. stockJuly 2025 Closing Moves & Fast Moving Stock Watchlists - fcp.pa.gov.br
Is SciSparc Ltd. stock attractive for passive investorsJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - Fundação Cultural do Pará
SciSparc’s Promising Clinical Study on SCI-210 for Autism Spectrum Disorder - TipRanks
SciSparc Completes Acquisition of Neurothera Labs Inc. - TipRanks
Form 6-K: SciSparc finalizes TSXV deal, pharma portfolio moved - Stock Titan
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):